Patent ID: 9498458
Filing Date: 2016-11-22
CPC Classification: A61K,A61P

Claim Text:
1. A method of inhibiting or treating fibrosis in a patient suffering therefrom, the method comprising: administering to the patient an effective amount of a compound of Formula (I), a metabolite of the compound of Formula (I), an ester of the compound of Formula (I), or a metabolite of the ester of the compound of Formula (I), or a pharmaceutically acceptable salt of each thereof: wherein: m is an integer from 2 to 5, inclusive; n is an integer from 3 to 8, inclusive; and X wherein: the fibrosis excludes (a) pulmonary fibrosis and (b) excludes hepatic fibrosis provided that the hepatic fibrosis excluded is not viral hepatitis induced fibrosis or alcoholic liver damage induced liver fibrosis.